The latest report by IMARC Group, titled “Immunohematology Market Report by Product (Analyzing Systems, Reagents and Consumables), Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-Magnetized Technology (EMT), and Others), Application (Blood-Related Diseases, HIV, Hepatitis, Blood Transfusion, and Others), End-User (Hospitals, Blood Banks, Diagnostic Laboratories, and Others), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the immunohematology market forecast.

What is the outlook for the global immunohematology market?
The global immunohematology market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.

Major Comapnies in the Immunohematology Industry:

• Abbott
• Antisel
• BD (Becton Dickinson and Company)
• Beckman Coulter Inc. (Danaher Corporation)
• Bio-Rad Laboratories Inc.
• Hoffmann-La Roche Ltd.
• Grifols S.A.
• Merck KGaA
• MTC Invitro Diagnostics AG
• Ortho-Clinical Diagnostics Inc (The Carlyle Group)
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc

Factors Affecting the Growth of the Immunohematology Industry:

• Rising Prevalence of Blood Disorders:

The escalating demand for immunohematology due to the increasing prevalence of blood disorders like anemia, hemophilia, and sickle cell disease among the masses around the world is supporting the growth of the market. Immunohematology plays a crucial role in diagnosing and managing these disorders by providing accurate blood typing, cross-matching, and compatibility testing for safe transfusions. Besides this, healthcare facilities and blood banks are increasingly relying on immunohematology solutions to ensure optimal patient care and blood transfusion safety as people are being affected by these disorders.

• Growing Need for Blood Transfusions:

The increasing need for blood transfusions due to surgeries, trauma cases, and chronic diseases is contributing to the growth of the market. Moreover, the rising demand for compatible blood products is bolstering the market growth. The growing number of medical procedures among individuals is also positively influencing the market. Immunohematology testing is essential in determining blood type compatibility between donors and recipients, reducing the risk of adverse reactions while ensuring successful transfusions. Apart from this, the increasing awareness about the importance of immunohematology in enhancing patient outcomes and reducing complications associated with blood transfusions is impelling the market growth.

• Advancements in Blood Screening Technologies:

Innovations in immunohematology testing technologies, such as molecular techniques and automation, are propelling the market growth. These innovations improve the speed, accuracy, and efficiency of blood typing and compatibility testing, enhancing patient safety and healthcare efficiency. Healthcare providers can make more informed decisions regarding blood transfusions with automated systems streamlining laboratory workflows and molecular techniques offering enhanced sensitivity and specificity. As a result, these advancements contribute to reducing turnaround times for test results, allowing for quick intervention and improved patient care.

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/immunohematology-market/requestsample

Immunohematology Market Report Segmentation:

By Product:

• Analyzing Systems
• Reagents and Consumables

Reagents and consumables represent the largest segment, which can be accredited to the rising focus on blood safety.   

By Technology:

• Biochips
• Gel Cards
• Microplates
• Polymerase Chain Reaction
• Erythrocyte-Magnetized Technology (EMT)
• Others

Polymerase chain reaction holds the biggest market share as it can detect minor blood group antigens.  

By Application:

• Blood-Related Diseases
• HIV
• Hepatitis
• Blood Transfusion
• Others

HIV accounts for the largest market share due to the increasing focus on blood-related conditions, such as blood typing, compatibility testing, and transfusion medicine.       

By End-User:

• Hospitals
• Blood Banks
• Diagnostic Laboratories
• Others

Hospitals exhibit a clear dominance in the market on account of the presence of well-equipped laboratories staffed with trained personnel who perform immunohematology tests on-site.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys a leading position in the immunohematology market, which can be attributed to the advanced healthcare infrastructure, including hospitals, clinics, and diagnostic laboratories.   

Global Immunohematology Market Trends:
Governing agencies of various countries are organizing campaigns to promote voluntary blood, which is supporting the market growth. These initiatives help ensure an adequate supply of blood products for transfusions. Moreover, healthcare facilities rely on immunohematology testing to determine donor-recipient compatibility accurately. Furthermore, the rising awareness about the importance of immunohematology in maintaining blood transfusion safety is impelling the market growth.
Apart from this, the growing demand for immunohematology among the geriatric population, as they are more susceptible to blood-related disorders and chronic diseases, is offering a positive market outlook.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=2256&flag=C

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

​IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163